15 results match your criteria: "Dr. Balaji Diabetes Care Centre[Affiliation]"
J Obstet Gynaecol India
December 2020
Department of Diabetology, Dr V Seshiah and Dr Balaji Diabetes Care Centre and Research Institution, Chennai, India.
Aim Of The Study: Studies have shown that gestational diabetes mellitus (GDM) causes disproportionate growth and increased adiposity in their newborns; however, the effect of gestational glucose intolerance (GGI), i.e., 2 h plasma glucose (PG) between 120 and 139 mg/dl in pregnancy on their newborns growth and adiposity is not well established.
View Article and Find Full Text PDFInt J Environ Res Public Health
April 2020
Global Health Section, Department of Public Health, University of Copenhagen, Oester Farimagsgade 5, 1014 Copenhagen, Denmark.
Gestational diabetes mellitus (GDM) is associated with a range of adverse pregnancy outcomes as well as increased risk of future type 2 diabetes and cardiovascular disease. In India, 10%-35% of pregnant women develop GDM. In this study, we investigated women's experiences with the dietary and pharmaceutical treatment for GDM in rural and urban Tamil Nadu, India.
View Article and Find Full Text PDFBMC Pregnancy Childbirth
August 2017
Department of Public Health, University of Copenhagen, Oester Farimagsgade 5, 1014, Copenhagen, Denmark.
Background: In 2007, universal screening for gestational diabetes mellitus (GDM) was introduced in Tamil Nadu, India. To identify factors hindering or facilitating timely initiation and completion of the GDM screening and diagnosis process, our study investigated how pregnant women in rural and urban Tamil Nadu access and navigate different GDM related health services.
Methods: The study was carried out in two settings: an urban private diabetes centre and a rural government primary health centre.
PLoS One
August 2016
Global Health Section, Department of Public Health, University of Copenhagen, Copenhagen, Denmark.
Introduction: Hyperglycaemia in pregnancy (HIP), i.e. gestational diabetes mellitus (GDM) and diabetes in pregnancy (DIP), increases the risk of various short- and long-term adverse outcomes.
View Article and Find Full Text PDFIndian J Endocrinol Metab
February 2016
Diabetes in Pregnancy Study Group India, Bengaluru, Karnataka, India; International Association of Diabetes and Pregnancy Study Group, Bengaluru, Karnataka, India; Dr. Balaji Diabetes Care Centre and Dr. V. Seshiah Diabetes Research Institute, Bengaluru, Karnataka, India; Expert Group Committee on GDM, Bengaluru, Karnataka, India; Ministry of Health Government of India and Indian Council of Medical Research, Bengaluru, Karnataka, India.
Aims: This observational study aims to determine the frequency of occurrence of glucose intolerance in the early weeks of pregnancy.
Materials And Methods: New World Health Organization 2013 guidelines recommends "A Single Step Procedure" (SSP) as an option for diagnosing gestational diabetes mellitus (GDM). Pregnant women attending 131 prenatal clinics across India for the first time underwent SSP consisting of administration of 75 goral glucose irrespective of the last meal timing and to diagnose GDM with 2 h plasma glucose (PG) value ≥7.
Indian J Endocrinol Metab
May 2015
Dr. V. Seshiah Diabetes Research Institute, Dr. Balaji Diabetes Care Centre, Chennai, Tamil Nadu, India.
Indian J Endocrinol Metab
May 2014
Department of Endocrinology, Jawaharlal Institute of Postgraduate Medical Education and Research, Pondicherry, India.
Objectives: DiabCare India 2011 was a cross-sectional study in patients with diabetes mellitus, undertaken to investigate the relationship between diabetes control, management and complications in a subset of urban Indian diabetes patients treated at referral diabetes care centres in India.
Materials And Methods: This was a cross-sectional, multicentre (330 centres) survey in 6168 diabetes patients treated at general hospitals, diabetes clinics and referral clinics across India. Patient data, including medical and clinical examination reports during the past year were collected during their routine visit.
J Obstet Gynaecol India
April 2014
Dr. V. Seshiah Diabetes Research Institute & Dr. Balaji Diabetes Care Centre, Chennai, Tamil Nadu India.
Diabetic pregnancies have attendant risks. Adverse fetal, neonatal, and maternal outcomes in a diabetic pregnancy can be avoided by optimum glycemic control. Most pregnancies with GDM can be managed with non-insulinic management, which includes medical nutrition therapy.
View Article and Find Full Text PDFThe World Health Organization (WHO) has recently released updated recommendations on Diagnostic Criteria and Classification of Hyperglycaemia First Detected in Pregnancy which are likely to increase the prevalence of gestational diabetes mellitus (GDM). Any increase in the number of women with GDM has implications for health services since these women will require treatment and regular surveillance during the pregnancy. Some health services throughout the world may have difficulty meeting these demands since country resources for addressing the diabetes burden are finite and resource allocation must be prioritised by balancing the need to improve care of people with diabetes and finding those with undiagnosed diabetes, including GDM.
View Article and Find Full Text PDFIndian J Endocrinol Metab
July 2013
Director and Senior Consultant Diabetologist, Dr. Balaji Diabetes Care Centre and, Dr. V. Seshiah Diabetes Research Institute, Aminjikarai, Chennai, India.
Objective: This study was undertaken to assess the efficacy and safetyof pioglitazone in combination with other oral antidiabetics (OADs) in Indian patients with type 2 diabetes mellitus (T2DM).
Materials And Methods: This was an openlabel, prospective, no-randomized, single-center observational study conducted at a single center in India. A total of 958 adult patients with T2DM on OADs, with uncontrolled fasting (FBG) or postprandial blood glucose (PPG), were enrolled.
J Assoc Physicians India
June 2012
Diabetes Research Institute and Dr Balaji Diabetes Care Centre, # 729, P. H. Road, Aminjikarai, Chennai.
Diabetes Res Clin Pract
September 2012
Dr V. Seshiah Diabetes Research Institute and Dr Balaji Diabetes Care Centre, Chennai, India.
The prevalence of diabetes is increasing globally and the causes attributed are the ageing population, urbanization, obesity epidemic, physical inactivity and stressful modern life. While all these factors contribute to the epidemic of DM, intra-uterine exposures and gestational programming are emerging as potential risk factors. Gestational programming is a process whereby stimuli or stresses that occur at critical or sensitive periods of foetal development, permanently change structure, physiology, and metabolism, which predispose individuals to disease in adult life.
View Article and Find Full Text PDFBackground: Universal screening for gestational diabetes mellitus (GDM) is advocated in Indian women as they have the highest frequency of GDM among the South Asian population. For this the diagnostic procedure has to be simple, economical, and evidence based. Hence, this study was undertaken to compare point-of-care measured capillary whole blood glucose (CBG) with a glucometer and laboratory-estimated venous plasma glucose (VPG) and to suggest which is feasible as a diagnostic tool.
View Article and Find Full Text PDFIndian J Endocrinol Metab
July 2011
Clinical Epidemiology Division, Dr. V. Seshiah Diabetes Research Institute, Dr. Balaji Diabetes Care Centre, Aminjikarai, Chennai, India.
Objective: To assess the validity of Diabetes in Pregnancy Study Group India (DIPSI) guidelines, a modified version of the WHO criterion to diagnose gestational diabetes mellitus (GDM).
Materials And Methods: A total of 1 463 consecutive pregnant women in the second and third trimester of pregnancy underwent 75 g oral glucose tolerance test (OGTT) and 2-h plasma glucose (PG) was measured by the glucose oxidase-peroxidase (GOD-POD) method. GDM was diagnosed with 2-h PG ≥ 7.
J Assoc Physicians India
February 2010
Dr. V. Seshiah Diabetes Research Institute, Dr. Balaji Diabetes Care Centre, Chennai 600029, Tamilnadu, India.
Objective: The objective of the study was to compare premixed insulin aspart 30 (BIAsp 30) vs premixed human insulin 30 (BHI 30) on efficacy, safety, fetal and perinatal outcomes in pregnancies associated with gestational diabetes mellitus [GDM]. This was the first randomized study to use pre mixed insulin analogue [BIAsp] in GDM.
Methods: The study population consisted of 76 GDM women assigned to BIAsp 30 (group A) and an equal number to BHI 30 (group B).